CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 739 shares (grant or award)
- 4 Grant or award Director acquired 739 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 739 shares (grant or award)
- 4 Grant or award Director acquired 739 shares (grant or award)
- 4 Open-market sale Director sold 100 shares at $121.96 ($12,196)
- 4 Open-market sale Director sold 100 shares at $120.94 ($12,094)
- 4 Open-market sale Director sold 1,059 shares at $121.73 ($128,909)
- 4 Option exercise Chief Executive Officer acquired 9,248 shares (option exercise)
- 4 Open-market sale Director sold 100 shares at $114.30 ($11,430)
- 4 Open-market sale Director sold 100 shares at $116.86 ($11,686)
- 4 Shares withheld for taxes SVP Clinical Controls gave up 312 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - General Counsel gave up 278 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - Novus Biologicals gave up 534 shares (to pay taxes)
- 4 Open-market sale Director sold 100 shares at $113.62 ($11,362)
- 4 Open-market sale Director sold 1,059 shares at $110.01 ($116,505)
- 4 Open-market sale Director sold 5,000 shares at $111.37 ($556,862)
- 4 Open-market sale Director sold 5,000 shares at $111.15 ($555,773)
Page 18 of 35 · 695 filings